Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups

Although some prognostic models have better concordance with survival than the PS only model, the absolute improvement is small. More accurate prognostic models should be developed; the inclusion of tumor genetic variants may improve prognostic models.